Evidence map›Paper›PMID 37509430›Full record

ArticleBiomedicines2023

Hydrogen Sulfide Ameliorates SARS-CoV-2-Associated Lung Endothelial Barrier Disruption.

Olivier Escaffre, Peter Szaniszlo, Gabor Törő, Caitlyn L Vilas, Brenna J Servantes, Ernesto Lopez, Terry L Juelich, Corri B Levine, Susan L F McLellan, Jessica C Cardenas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Olivier EscaffreDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-0402-9698
Peter SzaniszloDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.
Gabor TörőDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.
Caitlyn L VilasJohn Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
Brenna J ServantesDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.
Ernesto LopezDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-3211-0098
Terry L JuelichDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Corri B LevineDepartment of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-0405-5191
Susan L F McLellanDepartment of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA.
Jessica C CardenasThe Center for Translational Injury Research, Department of Surgery, UTHealth McGovern Medical School, Houston, TX 77030, USA.
Alexander N FreibergDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0001-8413-8960
Katalin MódisDepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0002-0706-9196
The University of Texas Medical Branch at Galveston · USThe University of Texas Health Science Center at Houston · US

Funding

Department of Surgery University of Texas Medical Branch C14250
6 · The paper itself

Abstract

Recent studies have confirmed that lung microvascular endothelial injury plays a critical role in the pathophysiology of COVID-19. Our group and others have demonstrated the beneficial effects of H

Indexed as

COVID-19cytokineendothelial barrierhydrogen sulfideSARS-CoV-2TNF-α

Identifiers

PMID37509430
PMCPMC10376201
OpenAlexW4381741498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.